or Try an Advanced Search...

    Technical Analysis for HOOK - HOOKIPA Pharma Inc.

    Grade Last Price % Change Price Change
    F 0.63 6.17% 0.04
    HOOK closed up 6.17 percent on Monday, July 1, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical HOOK trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Expansion Breakdown Bearish Swing Setup 6.17%
    Reversal New Lows Setup Bearish Swing Setup 6.17%
    Outside Day Range Expansion 6.17%
    Wide Bands Range Expansion 6.17%
    Oversold Stochastic Weakness 6.17%
    Stochastic Buy Signal Bullish -3.35%
    Older End-of-Day Signals for HOOK ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 5 hours ago
    Gap Up Closed about 10 hours ago
    Down 3% about 10 hours ago
    Reversal New Lows Entry about 10 hours ago
    Fell Below Previous Day's Low about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HOOK Chart by TradingView
    Basic chart:

    Profile

    HOOKIPA Pharma Inc. Description

    HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Hepatitis B Transplantation Immunodeficiency Hepatitis B Virus Viral Disease Papillomavirus Gilead Sciences Immunotherapeutics Kidney Transplant

    Is HOOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 5 Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
    Jun 4 HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
    May 30 HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
    May 24 HOOKIPA stock falls 20% in wake of Phase 1/2 study results
    May 23 HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
    May 16 Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
    May 11 HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations
    May 9 HOOKIPA Pharma GAAP EPS of $0.11
    May 9 HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
    Apr 26 Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
    See more HOOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.13
    52 Week Low 0.41
    Average Volume 941,691
    200-Day Moving Average 0.68
    50-Day Moving Average 0.79
    20-Day Moving Average 0.73
    10-Day Moving Average 0.65
    Average True Range 0.06
    RSI (14) 37.11
    ADX 18.01
    +DI 13.55
    -DI 28.57
    Chandelier Exit (Long, 3 ATRs) 0.73
    Chandelier Exit (Short, 3 ATRs) 0.75
    Upper Bollinger Bands 0.89
    Lower Bollinger Band 0.56
    Percent B (%b) 0.2
    BandWidth 45.06
    MACD Line -0.05
    MACD Signal Line -0.04
    MACD Histogram -0.0107
    Fundamentals Value
    Market Cap 60.66 Million
    Num Shares 96.6 Million
    EPS -0.80
    Price-to-Earnings (P/E) Ratio -0.79
    Price-to-Sales 3.25
    Price-to-Book 0.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.74
    Resistance 3 (R3) 0.74 0.69 0.72
    Resistance 2 (R2) 0.69 0.66 0.70 0.72
    Resistance 1 (R1) 0.66 0.64 0.68 0.67 0.71
    Pivot Point 0.62 0.62 0.62 0.62 0.62
    Support 1 (S1) 0.58 0.59 0.60 0.59 0.54
    Support 2 (S2) 0.54 0.57 0.54 0.54
    Support 3 (S3) 0.51 0.54 0.53
    Support 4 (S4) 0.51